Cellectar Biosciences (CLRB) Preferred Shares (2016 - 2025)
Cellectar Biosciences (CLRB) posted Preferred Shares of $520778.0 for Q4 2025, little changed sequentially from $520778.0 in Q3 2025, and little changed YoY from $520778.0 in Q4 2024.
Cellectar Biosciences (CLRB) Preferred Shares (2016 - 2025) Analysis & Trends
Cellectar Biosciences has reported Preferred Shares for 10 years, with the latest figure at $520778.0 in Q4 2025.
- Quarterly Preferred Shares changed 0.0% year-over-year to $520778.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $520778.0 (changed 0.0% YoY) and the FY2025 annual result came in at $520778.0, changed 0.0% from the prior year.
- Preferred Shares held at $520778.0 in Q4 2025 per CLRB's latest filing, from $520778.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $11.7 million in Q1 2021 and troughed at -$1.4 million in Q1 2022.
- A 5-year average of $1.8 million and a median of $520778.0 in 2024 frame the typical range for Preferred Shares.
- The sharpest annual moves came in 2021 and 2022: Preferred Shares surged 923.09% in 2021, then plunged 200.0% in 2022.
- Over 5 years, Preferred Shares stood at $1.4 million in 2021, then changed by 0.0% to $1.4 million in 2022, then soared by 238.46% to $4.7 million in 2023, then slumped by 88.87% to $520778.0 in 2024, then changed by 0.0% to $520778.0 in 2025.
- According to Business Quant data, Preferred Shares over the past three periods registered $520778.0, $520778.0, and $520778.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | - |
| 10 | Cellectar Biosciences | 6.77 Mn | 6.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 520,778.00 |
| Sep 30, 2025 | 520,778.00 |
| Jun 30, 2025 | 520,778.00 |
| Mar 31, 2025 | 520,778.00 |
| Dec 31, 2024 | 520,778.00 |
| Sep 30, 2024 | 7.06 Mn |
| Jun 30, 2024 | 4.37 Mn |
| Mar 31, 2024 | -1.38 Mn |
| Dec 31, 2023 | 4.68 Mn |
| Sep 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -1.38 Mn |
| Mar 31, 2023 | -1.38 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | -1.38 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | -1.38 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 1.38 Mn |
| Jun 30, 2021 | 8.64 Mn |
| Mar 31, 2021 | 11.75 Mn |